Literature DB >> 3013652

The mu, kappa and delta properties of various opioid agonists.

A E Takemori, M Ikeda, P S Portoghese.   

Abstract

Using the delta-enriched mouse vas deferens and the kappa-enriched guinea-pig ileal longitudinal muscle preparations, a large variety of so-called 'mu, kappa, delta and sigma' opioid agonists were tested for their mu, kappa and delta properties. Buprenorphine and U50,488H appeared to be the most highly selective agonists for mu and kappa opioid receptors, respectively. Most ligands identified as specific agonists are in fact only selective and appear to interact at more than one receptor type.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013652     DOI: 10.1016/0014-2999(86)90709-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Pharmacological profile of PD 117302, a selective kappa-opioid agonist.

Authors:  G E Leighton; M A Johnson; K G Meecham; R G Hill; J Hughes
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

2.  Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.

Authors:  A H Mulder; D M Burger; G Wardeh; F Hogenboom; A L Frankhuyzen
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

3.  Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of mu opioid receptors in mice.

Authors:  M Baba; R Oishi; K Saeki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

4.  Brain mu and delta opioid receptors mediate different locomotor hyperactivity responses of the C57BL/6J mouse.

Authors:  G A Mickley; M A Mulvihill; M A Postler
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated.

Authors:  R Bals-Kubik; A Herz; T S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.

Authors:  G Boachie-Ansah; R Sitsapesan; K A Kane; J R Parratt
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

7.  Effect of opioid receptor subtype-selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens.

Authors:  B Driessen; R Bültmann; I von Kügelgen; K Starke
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  Effects of buprenorphine and methadone in methadone-maintained subjects.

Authors:  S L Walsh; H L June; K J Schuh; K L Preston; G E Bigelow; M L Stitzer
Journal:  Psychopharmacology (Berl)       Date:  1995-06       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.